235 related articles for article (PubMed ID: 23880190)
1. Inhibition of ileal apical but not basolateral bile acid transport reduces atherosclerosis in apoE⁻/⁻ mice.
Lan T; Haywood J; Dawson PA
Atherosclerosis; 2013 Aug; 229(2):374-80. PubMed ID: 23880190
[TBL] [Abstract][Full Text] [Related]
2. Impact of Inhibiting Ileal Apical versus Basolateral Bile Acid Transport on Cholesterol Metabolism and Atherosclerosis in Mice.
Dawson PA
Dig Dis; 2015; 33(3):382-7. PubMed ID: 26045273
[TBL] [Abstract][Full Text] [Related]
3. Mouse organic solute transporter alpha deficiency alters FGF15 expression and bile acid metabolism.
Lan T; Rao A; Haywood J; Kock ND; Dawson PA
J Hepatol; 2012 Aug; 57(2):359-65. PubMed ID: 22542490
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial drug treatment increases intestinal bile acid absorption via elevated levels of ileal apical sodium-dependent bile acid transporter but not organic solute transporter α protein.
Miyata M; Hayashi K; Yamakawa H; Yamazoe Y; Yoshinari K
Biol Pharm Bull; 2015; 38(3):493-6. PubMed ID: 25757934
[TBL] [Abstract][Full Text] [Related]
5. Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice.
Slijepcevic D; Roscam Abbing RLP; Katafuchi T; Blank A; Donkers JM; van Hoppe S; de Waart DR; Tolenaars D; van der Meer JHM; Wildenberg M; Beuers U; Oude Elferink RPJ; Schinkel AH; van de Graaf SFJ
Hepatology; 2017 Nov; 66(5):1631-1643. PubMed ID: 28498614
[TBL] [Abstract][Full Text] [Related]
6. Irinotecan-induced bile acid malabsorption is associated with down-regulation of ileal Asbt (Slc10a2) in mice.
Shi AX; Zhou Y; Zhang XY; Zhao YS; Qin HY; Wang YP; Wu XA
Eur J Pharm Sci; 2017 May; 102():220-229. PubMed ID: 28288854
[TBL] [Abstract][Full Text] [Related]
7. Hepatic overexpression of Abcb11 in mice promotes the conservation of bile acids within the enterohepatic circulation.
Henkel AS; Gooijert KE; Havinga R; Boverhof R; Green RM; Verkade HJ
Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(2):G221-6. PubMed ID: 23139217
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE-/- mice by SC-435.
Bhat BG; Rapp SR; Beaudry JA; Napawan N; Butteiger DN; Hall KA; Null CL; Luo Y; Keller BT
J Lipid Res; 2003 Sep; 44(9):1614-21. PubMed ID: 12810816
[TBL] [Abstract][Full Text] [Related]
9. An FGF15/19-TFEB regulatory loop controls hepatic cholesterol and bile acid homeostasis.
Wang Y; Gunewardena S; Li F; Matye DJ; Chen C; Chao X; Jung T; Zhang Y; Czerwiński M; Ni HM; Ding WX; Li T
Nat Commun; 2020 Jul; 11(1):3612. PubMed ID: 32681035
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of intestinal bile acid transporter Slc10a2 improves triglyceride metabolism and normalizes elevated plasma glucose levels in mice.
Lundåsen T; Andersson EM; Snaith M; Lindmark H; Lundberg J; Östlund-Lindqvist AM; Angelin B; Rudling M
PLoS One; 2012; 7(5):e37787. PubMed ID: 22662222
[TBL] [Abstract][Full Text] [Related]
11. The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis.
Rao A; Haywood J; Craddock AL; Belinsky MG; Kruh GD; Dawson PA
Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3891-6. PubMed ID: 18292224
[TBL] [Abstract][Full Text] [Related]
12. Ontogenetic development and spatial distribution of the ileal apical sodium-dependent bile acid transporter and the ileal lipid-binding protein in apoE knockout and C57BL/6 mice.
Håkansson P; Andersson I; Nyström S; Löfgren L; Amrot LF; Li H
Scand J Gastroenterol; 2002 Sep; 37(9):1089-96. PubMed ID: 12374235
[TBL] [Abstract][Full Text] [Related]
13. The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter.
Dawson PA; Hubbert M; Haywood J; Craddock AL; Zerangue N; Christian WV; Ballatori N
J Biol Chem; 2005 Feb; 280(8):6960-8. PubMed ID: 15563450
[TBL] [Abstract][Full Text] [Related]
14. The thyroid receptor β modulator GC-1 reduces atherosclerosis in ApoE deficient mice.
Kannisto K; Rehnmark S; Slätis K; Webb P; Larsson L; Gåfvels M; Eggertsen G; Parini P
Atherosclerosis; 2014 Dec; 237(2):544-54. PubMed ID: 25463087
[TBL] [Abstract][Full Text] [Related]
15. Perinatal Hypercholesterolemia Exacerbates Atherosclerosis Lesions in Offspring by Altering Metabolism of Trimethylamine-N-Oxide and Bile Acids.
Trenteseaux C; Gaston AT; Aguesse A; Poupeau G; de Coppet P; Andriantsitohaina R; Laschet J; Amarger V; Krempf M; Nobecourt-Dupuy E; Ouguerram K
Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2053-2063. PubMed ID: 28935756
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid treatment alters systemic bile acid homeostasis by regulating the biosynthesis and transport of bile salts.
Xiao Y; Yan W; Zhou K; Cao Y; Cai W
Dig Liver Dis; 2016 Jul; 48(7):771-9. PubMed ID: 27133208
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury.
Christidis G; Karatayli E; Hall RA; Weber SN; Reichert MC; Hohl M; Qiao S; Boehm U; Lütjohann D; Lammert F; Karatayli SC
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360670
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol feeding prevents hepatic accumulation of bile acids in cholic acid-fed farnesoid X receptor (FXR)-null mice: FXR-independent suppression of intestinal bile acid absorption.
Miyata M; Matsuda Y; Nomoto M; Takamatsu Y; Sato N; Hamatsu M; Dawson PA; Gonzalez FJ; Yamazoe Y
Drug Metab Dispos; 2009 Feb; 37(2):338-44. PubMed ID: 18988759
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.
Rao A; Kosters A; Mells JE; Zhang W; Setchell KD; Amanso AM; Wynn GM; Xu T; Keller BT; Yin H; Banton S; Jones DP; Wu H; Dawson PA; Karpen SJ
Sci Transl Med; 2016 Sep; 8(357):357ra122. PubMed ID: 27655848
[TBL] [Abstract][Full Text] [Related]
20. FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption.
Jung D; Inagaki T; Gerard RD; Dawson PA; Kliewer SA; Mangelsdorf DJ; Moschetta A
J Lipid Res; 2007 Dec; 48(12):2693-700. PubMed ID: 17823457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
